Evaluation of the treatment of cutaneous leishmaniasis with Epigallocatechin Gallate
Phase 2
- Conditions
- cutaneous leishmaniasis.Cutaneous leishmaniasisB55.1
- Registration Number
- IRCT20180526039848N2
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
There are at least two lesions, in one case intervention + glucantime and in the other lesion only glucantime is prescribed.
15 to 60 years
Skin lesions at least one centimeter in size
Leishmaniasis confirmed by a parasitologist
consent signature
Exclusion Criteria
People who do not use the drug according to the plan
People who do not go to the clinic on the scheduled days
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method esion size (diameter). Timepoint: Day of 7? 14? 21? 28? 35? 42. Method of measurement: Image J software.
- Secondary Outcome Measures
Name Time Method